Live news related to SARTORIUS STED BIO stock (FR0013154002): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Sartorius Stedim Biotech kicked off 2026 in line with expectations, posting a 7.9% growth in constant currency revenue in the first quarter, driven by…
Sartorius Stedim Biotech falls by 4.84% mid-morning to €175.10, on the same day it announced its Q1 2026 results. The company reports a 7.9% increase …
Sartorius Stedim Biotech drops more than 2% this Monday morning, in a downward trending Parisian market. The stock, which had rebounded by over 8% in …
This Tuesday, Sartorius Stedim Biotech shows a marked increase, bringing its share price to 178.90 euros mid-session. The stock significantly outperfo…
Sartorius Stedim Biotech drops over 2% at the start of the session this Monday, amid widespread tension in European markets. The stock is now trading …
Sartorius Stedim Biotech sees a 2.61% increase this Friday mid-session, reaching €173.30, in a generally rising Parisian market. This rebound occurs w…
Sartorius Stedim Biotech significantly declines mid-morning in a downward trending Paris market. The stock is trading around €169.20, down 2.31% from …
Sartorius Stedim Biotech climbs 6.41% this Wednesday morning to €175.90, amidst a strong rebound of the CAC 40, which is up 4.28% during the session. …
Sartorius Stedim Biotech falls 2.65% this Thursday to €163.25, in a sharply declining Paris market. The biopharmaceutical equipment specialist's stock…
Sartorius Stedim Biotech ended the week down, losing 2.31% to 167.40 euros this Friday, March 20. The stock is moving in a deteriorated market context…
